Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapy

Hsueh Ju Lu, Jen Kou Lin, Wei Shone Chen, Jeng Kai Jiang, Shung Haur Yang, Yuan Tzu Lan, Chun Chi Lin, Shih Ching Chang, Hao Wei Teng*

*此作品的通信作者

研究成果: Article同行評審

19 引文 斯高帕斯(Scopus)

摘要

Introduction: Left- and right-sided colon cancers were significantly different in epidemiologic, clinical and histological parameters. However, the impact of primary tumor location in metastatic colon cancer treated with front-line targeted triplet regimens is unclear, particularly in Asian populations. Methods: A total of 121 patients with KRAS exon 2 codon 12/13 wild-type metastatic colon cancer were enrolled between January 2007 and December 2013. All patients received one target agent, such as cetuximab or bevacizumab, as a front-line targeted triplet regimen. The impact of primary tumor location for cetuximab and bevacizumab groups was analyzed, respectively. Results: In cetuximab group, left-sided metastatic colon cancer was superior to right-sided metastatic colon cancer in objective response rate (70.1% vs 33.3%, P = 0.024), progression-free survival (15.0 vs 5.3 months, P < 0.001) and overall survival (35.8 vs 14.4 months, P = 0.031). Primary tumor location was an independent prognostic factor for progression-free survival (hazard ratio 0.240, 95% confidence interval 0.114–0.508, P < 0.001). However, in the bevacizumab group, there were no differences in outcomes for either side. Primary tumor location was insignificant for progression-free survival and overall survival in univariate analysis. Conclusion: Left-sided primary tumors were favored in cetuximab-based front-line targeted triplet regimen for metastatic colon cancer.

原文English
頁(從 - 到)207-215
頁數9
期刊Asia-Pacific Journal of Clinical Oncology
12
發行號3
DOIs
出版狀態Published - 1 9月 2016

指紋

深入研究「Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapy」主題。共同形成了獨特的指紋。

引用此